Found 6 results
Author Title [ Type(Desc)] Year
Filters: Author is Harmon, W  [Clear All Filters]
Journal Article
A. Tejani, Stablein, D., Alexander, S., Fine, R., and Harmon, W., Analysis of Rejection Outcomes and Implications. A Report of the North American Pediatric Renal Transplant Cooperative Study, Transplantation, vol. 59, no. 4, pp. 500-504, 1995.
J. Smith, Stablein, D., Singh, A., Harmon, W., and McDonald, R., Decreased Risk of Renal Allograft Thrombosis Associated With Interleukin-2 Receptor Antagonists: A Report of the NAPRTCS, Am J Transplant, vol. 6, pp. 585-588, 2006.
M. A. Baum, Stablein, D., Panzarino, V. M., Tejani, A., and Harmon, W., Graft loss due to recurrence eliminates the graft survival advantage of living donor (LD) over Cadaveric (CD) renal transplants (Tx) in children with focal segmental glomerulosclerosis (FSGS): A report of the North American Pediatric Transplant Cooperati, 1999.
R. McDonald, Smith, J., Ho, M., Lindblad, R., Ikle, D., Grimm, P., Wyatt, R., Arar, M., Liereman, D., Bridges, N., and Harmon, W., Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids, Am J Transplant, vol. 8, pp. 984-989, 2008.
K. - J van Holthe, Ho, P., Stablein, D., Harmon, W., and Baum, M., Outcome of Renal Transplantation for Wilms' Tumor and Denys-Drash Syndrome: A Report of the North American Pediatric Renal Transplant Cooperative Study, Pediatr Transplant, vol. 9, pp. 305-310, 2005.
W. Harmon, Meyers, K., Ingelfinger, J., McDonald, R., McIntosh, M., Ho, M., Spaneas, L., Palmer, J., Hawk, M., Geehan, C., Tinckam, K., Hancock, W., and Sayegh, M., Safety and Efficacy of a Calcineurin-Inhibitor Avoidance Regimen in Pediatric Renal Transplantation, J Am Soc Nephrol, vol. 17, pp. 1735-1745, 2006.